These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6412341)

  • 41. Clinical trials of multiple sclerosis therapies: improvements to demonstrate long-term patient benefit.
    Carroll WM
    Mult Scler; 2009 Aug; 15(8):951-8. PubMed ID: 19465446
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin (author's transl)].
    Frick E; Angstwurm H; Strauss G
    MMW Munch Med Wochenschr; 1974 Nov; 116(48):2105-12. PubMed ID: 4216823
    [No Abstract]   [Full Text] [Related]  

  • 43. [New therapeutic possibilities for disseminated sclerosis?].
    Wanscher B; Sørensen PS
    Ugeskr Laeger; 1994 Oct; 156(43):6353-8. PubMed ID: 7810008
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disability as an outcome in MS clinical trials.
    Ebers GC; Heigenhauser L; Daumer M; Lederer C; Noseworthy JH
    Neurology; 2008 Aug; 71(9):624-31. PubMed ID: 18480462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immunsuppressive treatment of multiple sclerosis. 2. Critical review of general results (author's transl)].
    Frick E; Angstwurm H; Strauss G
    MMW Munch Med Wochenschr; 1974 Nov; 116(45):1987-92. PubMed ID: 4216803
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of multiple sclerosis with azathioprine (Imuran)].
    Ciesielski T; Burczyk-Popko I; Goralski H; Sypniewski J; Cendrowski W
    Pol Tyg Lek; 1974 Jan; 29(3):101-2. PubMed ID: 4594954
    [No Abstract]   [Full Text] [Related]  

  • 47. Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis.
    Goodkin DE
    West J Med; 1994 Sep; 161(3):292-8. PubMed ID: 7975569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Multiple sclerosis with hypocomplementemia].
    Trouillas P; Moindrot J; Quincy C; Berthoux F; Aimard G; Devic M
    Nouv Presse Med; 1976 Mar; 5(12):779-80. PubMed ID: 772598
    [No Abstract]   [Full Text] [Related]  

  • 49. New options for early treatment of multiple sclerosis.
    Tintoré M
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S9-S11. PubMed ID: 19200870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Long-term interferon therapy. Effectiveness in multiple sclerosis continues].
    MMW Fortschr Med; 2002 May; Suppl 2():84. PubMed ID: 12070862
    [No Abstract]   [Full Text] [Related]  

  • 51. [Multiple sclerosis].
    Igata A
    Nihon Rinsho; 1970 Jul; 28(7):1886-91. PubMed ID: 4918043
    [No Abstract]   [Full Text] [Related]  

  • 52. The use of immunosuppressive agents in the treatment of multiple sclerosis: a critical review.
    Goodin DS
    Neurology; 1991 Jul; 41(7):980-5. PubMed ID: 2067661
    [No Abstract]   [Full Text] [Related]  

  • 53. Non-specific immunosuppressants in the treatment of multiple sclerosis.
    Confavreux C; Vukusic S
    Clin Neurol Neurosurg; 2004 Jun; 106(3):263-9. PubMed ID: 15177781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunotherapy of multiple sclerosis--current practice and future directions.
    Tullman MJ; Lublin FD; Miller AE
    J Rehabil Res Dev; 2002; 39(2):273-85. PubMed ID: 12051470
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prolonged treatment of multiple sclerosis with average doses of azathioprine. An evaluation of 15 years' experience].
    Lhermitte F; Marteau R; Roullet E; de Saxcé H; Loridan M
    Rev Neurol (Paris); 1984; 140(10):553-8. PubMed ID: 6438761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of IGA nephritis].
    Risler T; Braun N
    Dtsch Med Wochenschr; 2000 Aug; 125(34-35):996. PubMed ID: 11004910
    [No Abstract]   [Full Text] [Related]  

  • 57. [Diagnosis and treatment of multiple sclerosis. Update, 2003].
    Jarius S; Hohlfeld R; Voltz R
    MMW Fortschr Med; 2003 May; 145 Suppl 2():88-91, 93, 95. PubMed ID: 14579493
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Guidelines for drug treatment of multiple sclerosis].
    Kollegger H; Vass K; Marschall I; Koch G; Deecke L
    Wien Klin Wochenschr; 1993; 105(16):443-52. PubMed ID: 7692677
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of multiple sclerosis by Azathioprine. About 77 cases studied during 10 years (author's transl)].
    Aimard G; Confavreux C; Trouillas P; Devic M
    Rev Neurol (Paris); 1978 Mar; 134(3):215-22. PubMed ID: 360353
    [No Abstract]   [Full Text] [Related]  

  • 60. [Will there soon be a sub-type specific treatment? New approaches to multiple sclerosis therapy].
    MMW Fortschr Med; 2008 Apr; 150(15):17. PubMed ID: 18510111
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.